Four drugmakers, including Johnson & Johnson, went on trial Monday over claims they helped fuel the deadly opioid epidemic in the United States through deceptive marketing that downplayed the risks of addiction.
Four drugmakers, including Johnson & Johnson, went on trial Monday over claims they helped fuel the deadly opioid epidemic in the United States through deceptive marketing that downplayed the risks of addiction.